Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report)’s share price traded down 5.5% during mid-day trading on Friday . The stock traded as low as $0.9123 and last traded at $0.9123. 3,634 shares traded hands during mid-day trading, an increase of 63% from the average session volume of 2,235 shares. The stock had previously closed at $0.9650.
Relief Therapeutics Stock Performance
The company’s 50 day moving average is $1.76 and its 200 day moving average is $2.93.
Relief Therapeutics Company Profile
Relief Therapeutics AG is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.
The company’s lead product candidate, RLF‐100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.
See Also
- Five stocks we like better than Relief Therapeutics
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
